SD
Sonu Dokania
About Sonu Dokania
Data last updated:
Sonu Dokania is a Director at Ganpati Eco Ventures Private Limited (since 2014) and Director at Synaptial Pharmaceuticals Private Limited (since 2021). The companies operate in Trading and Chemicals. The largest current company by reported revenue is Ganpati Eco Ventures Private Limited at ₹81.5 Lakh (FY 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ganpati Eco Ventures Private Limited U50200BR2014PTC022908 | Director | 12 Sep 2014 | 2014 | ₹81.5 Lakh (FY 2016) | Active |
| Synaptial Pharmaceuticals Private Limited U24234RJ2021PTC075602 | Director | 30 Jun 2021 | 2021 | Active |
Board colleagues of Sonu Dokania
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sweta Singhania | 06962120 | Ganpati Eco Ventures Private Limited | Director |
| Paras Nath Singh | 09222007 | Synaptial Pharmaceuticals Private Limited | Director |
| Raghavendra Kumar Singh | 03182631 | Synaptial Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sonu Dokania
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sonu Dokania
Sonu Dokania currently holds 2 directorships: Ganpati Eco Ventures Private Limited (Director, since 12 Sep 2014, revenue ₹81.5 Lakh (FY 2016)); Synaptial Pharmaceuticals Private Limited (Director, since 30 Jun 2021).
Sonu Dokania was first appointed on 12 Sep 2014 as Director at Ganpati Eco Ventures Private Limited. The most recent appointment on record is 30 Jun 2021 at Synaptial Pharmaceuticals Private Limited.
The current boards of Sonu Dokania's companies include Sweta Singhania (Ganpati Eco Ventures Private Limited), Paras Nath Singh (Synaptial Pharmaceuticals Private Limited), Raghavendra Kumar Singh (Synaptial Pharmaceuticals Private Limited).